I believe it will start with a presentation at the JP Morgan Healthcare conference. Year's ago $IMGN, which I've been invested in for decades, eagerly awaited invitations to present there, but it was called the H & Q Healthcare conference back then. The invitations didn't come for several years, but finally did. I think that a presentation there is a big thing, and I hope the company permits it to be webcast, I believe they can, but it costs extra to do so.

Two things make this important, one is that JPM has put a cannabis based company in the company of primarily biotechs and pharmas. Secondly they're acknowledging the depth of the pipeline OWCP has developed, even if much of it is in preclinical or early stage clinical development.

Gary